Molecule
Tetracaine is an ester local anesthetic indicated for procedures requiring a rapid and short-acting topical ophthalmic anesthetic. It is available as ophthalmic solution and eye drops. MedsAcross supplies Tetracaine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
From the regulator-approved product information. Each section names its source.
Tetracaine Hydrochloride Ophthalmic Solution 0.5% is indicated for procedures requiring a rapid and short-acting topical ophthalmic anesthetic. Tetracaine Hydrochloride Ophthalmic Solution 0.5% is an ester local anesthetic indicated for procedures requiring a rapid and short-acting topical ophthalmic anesthetic.
Source: US FDA prescribing information
Tetracaine blocks sodium ion channels required for the initiation and conduction of neuronal impulses thereby affecting local anesthesia.
Source: US FDA prescribing information
One drop topically in the eye(s) as needed. Discard unused portion. Topical Administration One drop topically in the eye as needed.
Source: US FDA prescribing information
None. None
Source: US FDA prescribing information
Do not use intracamerally since use may damage corneal endothelial cells. Prolonged use or abuse may lead to corneal epithelial toxicity and may manifest as epithelial defects which may progress to permanent corneal damage. Patients should not touch the eye for at least 10-20 minutes after using anesthetic as accidental injuries can occur due to insensitivity of the eye. For Administration by Healthcare Provider: Tetracaine Hydrochloride Ophthalmic Solution 0.5% is not intended for patient self-administration.
Source: US FDA prescribing information
The following serious ocular adverse reactions are described elsewhere in the labeling: Corneal injury with Intracameral Use Corneal Toxicity Corneal Injury due to Insensitivity The following adverse reactions have been identified following use of Tetracaine Hydrochloride Ophthalmic Solution 0.5%. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure. Ocular Adverse Reactions Transient stinging, burning, and conjunctival redness, eye irritation, eye pain, ocular discomfort. Ocular adverse events: stinging, burning, conjunctival redness
Source: US FDA prescribing information
Store at 2°C to 25°C (36°F to 77°F). Protect from light.
Source: US FDA prescribing information
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
2 presentations of Tetracaine, sorted by availability.
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Tetracaine 5 mg/mL ophthalmic solutionOphthalmicGeneric name | — | US FDA | Available on request |
| Tetracaine 5 mg/mL eye dropsOphthalmicGeneric name | — | US FDA | Available on request |
Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.
| Register | Status | Source |
|---|---|---|
| US FDA | First approved 29 February 2016 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Conditions linked to Tetracaine in public data. This is not a list of approved uses, see the clinical information.
Yes, on request. MedsAcross lists 2 presentations of Tetracaine and sources them for licensed hospitals, importers and physicians against valid import documents.
Yes. The US FDA first approved Tetracaine on 29 February 2016, according to Drugs@FDA.
No listed presentation of Tetracaine is recorded as needing a cold chain. Storage conditions are shown on each presentation page.
Tetracaine is classified under ATC code C05AD02 (Tetracaine).
Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.